Hide, M., Park, H.-S., Igarashi, A., Ye, Y.-M., Kim, T.-B. and Yagami, A. 2017. Efficacy and Safety of Omalizumab in Japanese and Korean Patients with Chronic Idopathic/Spontaneous Urticaria (CIU/CSU: Results from the Phase 3 POLARIS Study. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s126. DOI:https://doi.org/10.25251/skin.1.supp.125.